Common-sense model of self-regulation to cluster fibromyalgia patients: results from a cross-sectional study in Italy.


Journal

Clinical and experimental rheumatology
ISSN: 0392-856X
Titre abrégé: Clin Exp Rheumatol
Pays: Italy
ID NLM: 8308521

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 11 03 2022
accepted: 04 04 2022
pubmed: 15 6 2022
medline: 29 6 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Fibromyalgia is a severe and disabling chronic pain syndrome affecting millions of people worldwide. Various patients' subgroups were identified using different atheoretical measures, hardly effective to tailor treatments. Previous literature findings showed the relevance of fibromyalgia patients' illness perceptions in adjusting to the disease. The present study aims to identify clusters of fibromyalgia patients based on their illness perceptions and investigate whether they can differ across pain, mood, physical functioning, catastrophising, and pain acceptance measures. Fifty-three newly referred fibromyalgia patients completed clinical and psychological questionnaires. Patients' subgroups were created by applying hierarchical cluster analysis to their answers to Illness Perception Questionnaire-Revised subscales. Potential differences across subgroups in outcome variables were tested. Cluster analysis identified two patient groups. Group A (32 patients) had a higher representation of fibromyalgia as a chronic disease with severe consequences, lower beliefs in personal and treatment control, and a higher fibromyalgia-related emotional distress than group B (21 patients). Clusters did not differ on pain intensity and duration. Group A, compared to group B, showed worse physical functioning and overall impairment due to fibromyalgia, a poorer psychological condition, a higher tendency to catastrophise, and less pain acceptance. Study findings reveal two fibromyalgia subgroups differing in emotional suffering and impairment despite similar pain intensity and duration. Patients' illness perceptions and attitudes towards pain, like catastrophising and acceptance, might be critical in adjusting to the disease. A detailed assessment of such risk and protective factors is critical to differentiate patients' subgroups with different needs and thus offering tailored treatments.

Identifiants

pubmed: 35699086
pii: 18533
doi: 10.55563/clinexprheumatol/cd7fa1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1175-1182

Auteurs

Michael Tenti (M)

ISAL Foundation, Institute for Research on Pain, Rimini, Italy. michael.tenti@fondazioneisal.it.

William Raffaeli (W)

ISAL Foundation, Institute for Research on Pain, Rimini, Italy.

Valentina Malafoglia (V)

ISAL Foundation, Institute for Research on Pain, Rimini, Italy.

Mery Paroli (M)

Anaesthesiology and Pain Therapy Unit, Santa Chiara University Hospital, Pisa, Italy.

Sara Ilari (S)

Institute of Research for Food Safety and Health (IRC_FSH), Department of Health Sciences, University Magna Graecia of Catanzaro, Italy.

Carolina Muscoli (C)

Institute of Research for Food Safety and Health (IRC_FSH), Department of Health Sciences, University Magna Graecia of Catanzaro, Italy.

Elena Fraccaroli (E)

Italian Patient Association for Fibromyalgia Syndrome, Italy.

Sara Bongiovanni (S)

Rheumatology Unit, ASST-Fatebenefratelli L. Sacco University Hospital, University of Milan, Italy.

Chiara Gioia (C)

Rheumatology Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.

Cristina Iannuccelli (C)

Rheumatology Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.

Manuela Di Franco (M)

Rheumatology Unit, Department of Clinical Internal, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Rome, Italy.

Paola Gremigni (P)

Department of Psychology, University of Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH